FDA updates data on serology test performance

Apr 28, 2021 - 03:39 PM
FDA-guidance

The Food and Drug Administration today updated its webpage on the performance of SARS-CoV-2 serology tests authorized for emergency use to help health care providers interpret these antibody test results for their patients. The update also clarifies the use of serology tests when assessing a patient’s adaptive immune response. 

Related News Articles

Headline
CMS webinar May 13 on building COVID-19 vaccine confidence
The Centers for Medicare & Medicaid Services Office of Minority Health will host a May 13 webinar on building COVID-19 vaccine confidence. Register for the…
Headline
CDC confirms lower likelihood of COVID-19 hospitalization following full vaccination
 A Centers for Disease Control and Prevention assessment affirms the ability of the two authorized mRNA COVID-19 vaccines to prevent hospitalization…
Headline
CDC lifts outdoor masking restrictions for fully vaccinated individuals, updates infection prevention and control recommendations for health care personnel
The Centers for Disease Control and Prevention today announced relaxed guidance for mask wearing, stating that individuals fully vaccinated against COVID-19 no…
Headline
CDC advisory committee recommends resumption of Johnson & Johnson COVID-19 vaccine
An independent Centers for Disease Control and Prevention advisory committee today recommended immediate resumption of the administration of Johnson &…
Headline
FDA revokes emergency use authorization for monoclonal antibody bamlanivimab
The Food and Drug Administration April 16 revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab…
News
FDA revokes emergency use authorization for monoclonal antibody bamlanivimab
The Food and Drug Administration today revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab,…